Literature DB >> 20057921

Application of Proteomic Analysis to Renal Disease in the Clinic.

Bruce A Julian1, Hitoshi Suzuki, Goce Spasovski, Yusuke Suzuki, Yasuhiko Tomino, Jan Novak.   

Abstract

Entities:  

Year:  2009        PMID： 20057921      PMCID： PMC2802493          DOI： 10.1002/prca.200800244

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN： 1862-8346            Impact factor:   3.494


× No keyword cloud information.
  41 in total

Review 1.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility.

Authors:  Nader Rifai; Michael A Gillette; Steven A Carr
Journal:  Nat Biotechnol       Date:  2006-08       Impact factor: 54.908

Review 2.  Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future.

Authors:  David M Good; Visith Thongboonkerd; Jan Novak; Jean-Loup Bascands; Joost P Schanstra; Joshua J Coon; Anna Dominiczak; Harald Mischak
Journal:  J Proteome Res       Date:  2007-10-31       Impact factor: 4.466

3.  Renoprotective effects of renin-angiotensin-system inhibitors.

Authors:  Dick de Zeeuw; Edmund J Lewis; Giuseppe Remuzzi; Barry M Brenner; Mark E Cooper
Journal:  Lancet       Date:  2006-03-18       Impact factor: 79.321

4.  Impact of diabetic nephropathy and angiotensin II receptor blockade on urinary polypeptide patterns.

Authors:  Kasper Rossing; Harald Mischak; Hans-Henrik Parving; Per K Christensen; Michael Walden; Meike Hillmann; Thorsten Kaiser
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

5.  Occurrence of mesangial IgA and IgM deposits in a control necropsy population.

Authors:  R Sinniah
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

6.  Nephropathy in type 1 diabetes: a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study.

Authors:  Trevor J Orchard; Yue-Fang Chang; Robert E Ferrell; Nancy Petro; Demetrius E Ellis
Journal:  Kidney Int       Date:  2002-09       Impact factor: 10.612

7.  Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease.

Authors:  Janet K Snell-Bergeon; David M Maahs; Lorraine G Ogden; Gregory L Kinney; John E Hokanson; Eric Schiffer; Marian Rewers; Harald Mischak
Journal:  Diabetes Technol Ther       Date:  2009-01       Impact factor: 6.118

8.  Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis.

Authors:  Dan Theodorescu; Stefan Wittke; Mark M Ross; Michael Walden; Mark Conaway; Ingo Just; Harald Mischak; Henry F Frierson
Journal:  Lancet Oncol       Date:  2006-03       Impact factor: 41.316

9.  2007 Young Investigator Award: TRP'ing into a new era for glomerular disease.

Authors:  Michelle P Winn
Journal:  J Am Soc Nephrol       Date:  2008-04-23       Impact factor: 10.121

10.  Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis.

Authors:  Stephane Decramer; Stefan Wittke; Harald Mischak; Petra Zürbig; Michael Walden; François Bouissou; Jean-Loup Bascands; Joost P Schanstra
Journal:  Nat Med       Date:  2006-03-19       Impact factor: 53.440
View more
  3 in total

Review 1.  Current treatment of IgA nephropathy.

Authors:  Jürgen Floege; Thomas Rauen; Sydney C W Tang
Journal:  Semin Immunopathol       Date:  2021-09-08       Impact factor: 9.623

2.  New Insights into the Pathogenesis of IgA Nephropathy.

Authors:  Jan Novak; Dana Rizk; Kazuo Takahashi; XianWen Zhang; Qi Bian; Hirouki Ueda; Yoshimi Ueda; Colin Reily; Ling-Yun Lai; Chuanming Hao; Lea Novak; Zhi-Qiang Huang; Matthew B Renfrow; Hitoshi Suzuki; Bruce A Julian
Journal:  Kidney Dis (Basel)       Date:  2015-05-01

Review 3.  The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy.

Authors:  Barbora Knoppova; Colin Reily; Nicolas Maillard; Dana V Rizk; Zina Moldoveanu; Jiri Mestecky; Milan Raska; Matthew B Renfrow; Bruce A Julian; Jan Novak
Journal:  Front Immunol       Date:  2016-04-12       Impact factor: 7.561
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.